Showing results (61-70 of 166) with videos related to
Sort By:
Pageof 17
Nederlands Tijdschrift Voor Geneeskunde|June 13, 2019
[Immunotherapy for cancer: from medical breakthrough to application in daily practice]Nick R P Dekker, Jos A Stigt, Otto Visser, et al.Journal of Surgical Oncology|March 19, 2013
Increasing incidence and survival of a rare skin cancer in the Netherlands. A population-based study of 2,220 cases of skin adnexal carcinomaHanneke Stam, Peter J F M Lohuis, Biljana Zupan-Kajcovski, et al.Ejhaem|July 18, 2022
Conditional relative survival among patients with chronic lymphocytic leukaemia: A population-based study in the NetherlandsLina van der Straten, Mark-David Levin, Otto Visser, et al.International Journal of Cancer|June 16, 2026
Availability of Stage Information From Cancer Registries Providing Data to the European Cancer Information System for Six Selected CancersCristina Bosetti, Otto Visser, Liesbet Van Eycken, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 14, 2015
Rare cancers in The Netherlands: a population-based studyJan M van der Zwan, Boukje A C van Dijk, Otto Visser, et al.World Journal of Gastroenterology|January 29, 2011
Evaluation of Cladribine treatment in refractory celiac disease type IIGreetje J Tack, Wieke H M Verbeek, Abdul Al-Toma, et al.European Journal of Public Health|September 4, 2010
The validity of the mortality to incidence ratio as a proxy for site-specific cancer survivalFatemeh Asadzadeh Vostakolaei, Henrike E Karim-Kos, Maryska L G Janssen-Heijnen, et al.Cancers|September 13, 2025
Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment EffectsShahin Roshani, Flora E van Leeuwen, Sara Rossetti, et al.European Journal of Public Health|December 22, 2021
Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European surveyLuciana Neamţiu, Carmen Martos, Francesco Giusti, et al.British Journal of Haematology|October 4, 2021
Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population-based study in the Netherlands, 1989-2018Karima Amaador, Marie José Kersten, Otto Visser, et al.Pageof 17